Difference between revisions of "Part:BBa K758003"

 
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
−
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K758003 short</partinfo>
 
<partinfo>BBa_K758003 short</partinfo>
Line 5: Line 4:
 
This part includes five UAS(Upstream Activating Sequence) sequences, GAL4 binding sites.
 
This part includes five UAS(Upstream Activating Sequence) sequences, GAL4 binding sites.
 
This part is working in mainly eukaryotic life.
 
This part is working in mainly eukaryotic life.
 +
<html>
 +
 +
<head>
 +
 +
</head>
  
 +
<body>
 +
<h2 class="pageContent-main__title">
 +
        <!--put tile here, <h2>title</h2>, class="pageContent-main__title" means it is the main title-->
 +
        Supplementary Experiment
 +
    </h2>
 +
    <div class="pageContent-main__textBox">
 +
        <!--all the content must included in this div-->
 +
        <p>Group: CSU_CHINA 2021
 +
        </p>
 +
    </div>
 +
    <div class="pageContent-main__textBox">
 +
        <!--all the content must included in this div-->
 +
        <p>Author: Xingjun Zhao
 +
        </p>
 +
    </div>
 +
    <div class="pageContent-main__textBox">
 +
        <!--all the content must included in this div-->
 +
        <p>UAS (BBa_K758003) is a piece of small DNA sequence that can be recognized and combined by GAL4 DBD. Team iGEM12_KIT-Kyoto repeated UAS 5 times when using it. In our design, considering of that the mutual effect of our blue light protein would
 +
            reduce the efficiency and the whole pathway is relatively long, while the react time of our system should be as short as possible, we have made some alterations
 +
        </p>
 +
        <p>We have repeated the UAS before promoter for 9 times. The purpose of constructing 9XUAS-Ad-LUC (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K3734032" target="_blank">BBa_K3734016</a>) and 9XUAS-Ad-insulin (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K3734033"
 +
                target="_blank">BBa_K3734033</a>) is to enhance the recognition and combination of GAL4 DBD, improve the efficiency of downstream target gene activation.
 +
        </p>
 +
    </div>
 +
    <div class="pageContent-main__textBox">
 +
        <!--all the content must included in this div-->
 +
        <p style="text-align: center;">
 +
            <img width="400px" src="https://2021.igem.org/wiki/images/a/ad/T--CSU_CHINA--improve2.png"></p>
 +
        <!--put image's url here-->
 +
        <p style="width: 80%;text-align:center;font-size: .9rem; margin: -1rem auto 1rem auto; color: #888;">Fig.1 Light controlled system testing experiment </p>
 +
        <p style="text-align: center;">
 +
            <img width="400px" src="https://2021.igem.org/wiki/images/e/ef/T--CSU_CHINA--improve3.png"></p>
 +
        <!--put image's url here-->
 +
        <p style="width: 80%;text-align:center;font-size: .9rem; margin: -1rem auto 1rem auto; color: #888;">Fig.2 Insulin concentration in supernatant (excluding insulin in medium) after blue light irradiation and dark treatment respectively</p>
 +
    </div>
 +
</body>
 +
</html>
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===

Latest revision as of 19:37, 20 October 2021

UAS, this part consists of five UAS sequences and hsp70 TATA.

This part includes five UAS(Upstream Activating Sequence) sequences, GAL4 binding sites. This part is working in mainly eukaryotic life.

Supplementary Experiment

Group: CSU_CHINA 2021

Author: Xingjun Zhao

UAS (BBa_K758003) is a piece of small DNA sequence that can be recognized and combined by GAL4 DBD. Team iGEM12_KIT-Kyoto repeated UAS 5 times when using it. In our design, considering of that the mutual effect of our blue light protein would reduce the efficiency and the whole pathway is relatively long, while the react time of our system should be as short as possible, we have made some alterations

We have repeated the UAS before promoter for 9 times. The purpose of constructing 9XUAS-Ad-LUC (BBa_K3734016) and 9XUAS-Ad-insulin (BBa_K3734033) is to enhance the recognition and combination of GAL4 DBD, improve the efficiency of downstream target gene activation.

Fig.1 Light controlled system testing experiment

Fig.2 Insulin concentration in supernatant (excluding insulin in medium) after blue light irradiation and dark treatment respectively

Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 4
    Illegal PstI site found at 247
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 4
    Illegal PstI site found at 247
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 377
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 4
    Illegal PstI site found at 247
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 4
    Illegal PstI site found at 247
  • 1000
    COMPATIBLE WITH RFC[1000]